Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

Core Insights - Seer, Inc. is participating in the Canaccord Genuity 44th Annual Growth Conference in Boston, MA, highlighting its position in the life sciences sector [1] - The management will engage in a fireside chat on August 14th, 2024, providing an opportunity for investors to gain insights into the company's developments [2] Company Overview - Seer is a life sciences company focused on developing transformative products for proteomics, specifically through its Proteograph Product Suite [3] - The Proteograph Product Suite includes engineered nanoparticles, consumables, automation instrumentation, and software for deep proteomic analysis, designed to be efficient and user-friendly [3] - The product suite is intended for research use only and is not meant for diagnostic procedures [3]